RE:Q4 financialsDon't bank on sales from seniors this quarter (or honestly for the next year or so). At this point, with the market still very much being in its infancy, the product deriviatives just aren't there. Moreover, it's extremely expensive, and the fact of the matter is, most seniors absolutely cannot afford to purchase medical cannabis products.
That said, now is the time to build these relationships and establish ourselves as a leader in the space. You have to plant the seed now to let the plants take their roots. By rolling our the proprietary educational platform out and educating the stakesholders in assisted living and LTC facilities now, they will all be looking to us as the leader down the line. The ulitmate goal here is two-fold: two buy or build the deriviative products that this demographic needs to consume (pills, patches, sprays, etc.), and to attain covered-cost status which would make this demographic the most stick and dependable.
WMD has no issue moving their product. I definitely classify it a being high-mid grade cannabis. Any other LP would take everything in their vault if they put it on the market today.